Tomáš Gucký

672 total citations
36 papers, 512 citations indexed

About

Tomáš Gucký is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Tomáš Gucký has authored 36 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Tomáš Gucký's work include Synthesis and Characterization of Heterocyclic Compounds (9 papers), Cancer-related Molecular Pathways (7 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Tomáš Gucký is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (9 papers), Cancer-related Molecular Pathways (7 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Tomáš Gucký collaborates with scholars based in Czechia, South Africa and Germany. Tomáš Gucký's co-authors include Vladimı́r Kryštof, Eva Řezníčková, Radek Jorda, Miroslav Strnad, Jiří Voller, Petr Džubák, Karel Berka, Marián Hajdúch, Václav Bazgier and Marek Zatloukal and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Tomáš Gucký

33 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomáš Gucký Czechia 14 218 209 115 74 65 36 512
Hui-Yi Shiao Taiwan 12 304 1.4× 271 1.3× 114 1.0× 25 0.3× 66 1.0× 13 626
Danny Hsu United States 12 184 0.8× 214 1.0× 117 1.0× 27 0.4× 32 0.5× 27 510
Eva Řezníčková Czechia 15 245 1.1× 259 1.2× 146 1.3× 11 0.1× 85 1.3× 44 541
Marilia Barreca Italy 17 291 1.3× 272 1.3× 72 0.6× 13 0.2× 55 0.8× 30 597
Lijiao Wang China 10 97 0.4× 157 0.8× 67 0.6× 41 0.6× 54 0.8× 24 334
Fathima R. Kona United States 10 161 0.7× 282 1.3× 141 1.2× 23 0.3× 12 0.2× 11 493
Yanle Zhi China 12 143 0.7× 264 1.3× 65 0.6× 24 0.3× 30 0.5× 27 444
Christine Basmadjian France 10 86 0.4× 417 2.0× 106 0.9× 23 0.3× 25 0.4× 11 588
AT McGown United Kingdom 8 151 0.7× 236 1.1× 141 1.2× 17 0.2× 25 0.4× 11 495
Jiaqi Cao China 6 65 0.3× 363 1.7× 188 1.6× 23 0.3× 119 1.8× 9 618

Countries citing papers authored by Tomáš Gucký

Since Specialization
Citations

This map shows the geographic impact of Tomáš Gucký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Gucký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Gucký more than expected).

Fields of papers citing papers by Tomáš Gucký

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Gucký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Gucký. The network helps show where Tomáš Gucký may publish in the future.

Co-authorship network of co-authors of Tomáš Gucký

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Gucký. A scholar is included among the top collaborators of Tomáš Gucký based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Gucký. Tomáš Gucký is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Řezníčková, Eva, Radek Jorda, Milan Dejmek, et al.. (2023). Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping. Journal of Medicinal Chemistry. 66(16). 11133–11157. 8 indexed citations
2.
Gucký, Tomáš, et al.. (2022). Synthesis and biological activity evaluation of novel 2,6,9-trisubstituted purine conjugates as potential protein kinases inhibitors. Bioorganic & Medicinal Chemistry Letters. 60. 128603–128603. 3 indexed citations
3.
Gucký, Tomáš, et al.. (2022). Synthesis and biological activity evaluation of novel 3,5,7-trisubstituted pyrazolo[1,5-a]pyrimidines. Bioorganic & Medicinal Chemistry Letters. 80. 129096–129096. 4 indexed citations
4.
Jansa, Josef, Radek Jorda, Jana Škerlová, et al.. (2021). Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure. European Journal of Medicinal Chemistry. 216. 113309–113309. 10 indexed citations
5.
Gucký, Tomáš, et al.. (2021). A stable isotope dilution method for a highly accurate analysis of karrikins. Plant Methods. 17(1). 37–37. 2 indexed citations
6.
Gucký, Tomáš, Vladimı́r Kryštof, Miroslav Strnad, et al.. (2020). in vitro and in silico studies of interaction of synthetic 2,6,9-trisubstituted purine kinase inhibitors BPA-302, BP-21 and BP-117 with liver drug-metabolizing cytochromes P450. Physiological Research. 69(Suppl 4). S627–S636. 1 indexed citations
7.
Řezníčková, Eva, Tomáš Gucký, Veronika Kováčová, et al.. (2019). Activity of 2,6,9-trisubstituted purines as potent PDGFRα kinase inhibitors with antileukaemic activity. European Journal of Medicinal Chemistry. 182. 111663–111663. 9 indexed citations
8.
Voller, Jiří, Lenka Zahajská, Lucie Plíhalová, et al.. (2019). 6-Substituted purines as ROCK inhibitors with anti-metastatic activity. Bioorganic Chemistry. 90. 103005–103005. 6 indexed citations
9.
Béreš, Tibor, et al.. (2019). Intralaboratory comparison of analytical methods for quantification of major phytocannabinoids. Analytical and Bioanalytical Chemistry. 411(14). 3069–3079. 18 indexed citations
10.
Široká, Jitka, Martina Čečková, Lubor Urbánek, et al.. (2018). LC-MS/MS method for determination of cyclin-dependent kinase inhibitors, BP-14 and BP-20, and its application in pharmacokinetic study in rat. Journal of Chromatography B. 1089. 24–32.
11.
Zahajská, Lenka, Jaroslav Nisler, Jiří Voller, et al.. (2016). Preparation, characterization and biological activity of C8-substituted cytokinins. Phytochemistry. 135. 115–127. 8 indexed citations
12.
Řezníčková, Eva, Tomáš Gucký, Marek Zatloukal, et al.. (2015). 2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro. Bioorganic & Medicinal Chemistry Letters. 25(11). 2298–2301. 10 indexed citations
13.
Grubinger, Markus, Eva Řezníčková, Thomas S. Weiß, et al.. (2013). Novel Inhibitors of Cyclin-Dependent Kinases Combat Hepatocellular Carcinoma without Inducing Chemoresistance. Molecular Cancer Therapeutics. 12(10). 1947–1957. 27 indexed citations
14.
Liebl, Johanna, Vladimı́r Kryštof, Libor Havlı́ček, et al.. (2013). Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors. PLoS ONE. 8(1). e54607–e54607. 23 indexed citations
15.
Zatloukal, Marek, Radek Jorda, Tomáš Gucký, et al.. (2012). Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases. European Journal of Medicinal Chemistry. 61. 61–72. 37 indexed citations
16.
Gucký, Tomáš, Eva Řezníčková, Petr Džubák, Marián Hajdúch, & Vladimı́r Kryštof. (2010). ChemInform Abstract: Synthesis and Anticancer Activity of Some 1,5‐Diaryl‐3‐(3,4,5‐trihydroxyphenyl)‐1H‐pyrazolo[4,3‐e] [1,2,4]triazines.. ChemInform. 41(41). 1 indexed citations
17.
18.
Gucký, Tomáš, et al.. (2003). Cyclocondensation Reactions of Heterocyclic Carbonyl Compounds VIII. Heterocyclic Communications. 9(5). 437–442. 3 indexed citations
19.
Gucký, Tomáš, et al.. (2002). SYNTHESIS OF THE NEW SERIES OF NOVEL HETEROCYCLIC SKELETON ISOXAZOLO [4,5-e] 1,2,4-TRIAZINES AND NEW SERIES OF THE PYRAZOLO [4,3-e] 1,2,4-TRIAZINES. Heterocyclic Communications. 8(6). 613–616. 1 indexed citations
20.
Gucký, Tomáš, et al.. (2001). SYNTHESIS OF SOME NEW 3,5,7-TRISUBSTITUTED PYRAZOLO|4,3-e|1,2,4-TRIAZINES. Heterocyclic Communications. 7(4). 349–352. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hui-Yi Shiao Breakdown of academic impact, for papers by Danny Hsu Breakdown of academic impact, for papers by Eva Řezníčková Breakdown of academic impact, for papers by Marilia Barreca Breakdown of academic impact, for papers by Lijiao Wang Breakdown of academic impact, for papers by Fathima R. Kona Breakdown of academic impact, for papers by Yanle Zhi Breakdown of academic impact, for papers by Christine Basmadjian Breakdown of academic impact, for papers by AT McGown Breakdown of academic impact, for papers by Jiaqi Cao
Rankless by CCL
2026